Drug Shortage Report for IRBESARTAN

Last updated on 2018-10-31 History
Report ID 62786
Drug Identification Number 02372347
Brand name IRBESARTAN
Common or Proper name IRBESARTAN
Company Name SANIS HEALTH INC
Market Status MARKETED
Active Ingredient(s) IRBESARTAN
Strength(s) 75MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-10-01
Actual start date 2018-10-01
Estimated end date 2018-10-31
Actual end date 2018-10-30
Shortage status Resolved
Updated date 2018-10-31
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1 PRESIDENTS CHOICE CIRCLE
BRAMPTON, ONTARIO
CANADA L6Y 5S5
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2018-10-01 English Compare
v2 2018-10-01 French Compare
v3 2018-10-02 English Compare
v4 2018-10-12 English Compare
v5 2018-10-12 French Compare
v6 2018-10-30 English Compare
v7 2018-10-30 French Compare
v8 2018-10-31 English Compare

Showing 1 to 8 of 8